Watch the discussion and learn how decisions are made here.
Introductions of panel members start at 8:55
Dr. Doran Fink presents the topics for discussion at 26:30
The presentations of the meeting:
- Epidemiology of COVID-19 in children 50:40
- Vaccine associated myocarditis 1:28:20
- Pfizer-BioNTech request 2:24:20
- FDA review of safety and effectiveness of vaccine in children 3:10:27
- Post-market active surveillance of COVID-19 vaccines in the pediatric population in the FDA BEST system 3:38:00
- Benefit-Risk analysis 3:43:22
- Open Public Hearing 4:36:21
- Q&A session 5:43:50
- Committee discussion and voting 6:45:00